Acquired Aplastic Anemia: What Have We Learned and What Is in the Horizon?

Research output: Contribution to journalReview articlepeer-review

Abstract

Acquired aplastic anemia (aAA) characterized by peripheral pancytopenia and bone marrow aplasia is a rare and serious disorder. Differential diagnosis includes constitutional bone marrow failure syndromes and myelodysplastic disorders. Autoimmune reaction to altered hematopoietic stem cells highlights the underlying mechanism. Matched related donor allogeneic hematopoietic stem cell transplantation is the ideal pediatric treatment; alternative approaches include immunosuppressive therapy and use of eltrombopag. Progression to clonal disorders can occur. Recently, alternative donor hematopoietic stem cell transplantation outcomes have significantly improved. Despite advances, aAA continues to be a challenge for hematologists.

Original languageEnglish
Pages (from-to)597-606
Number of pages10
JournalPediatric Clinics of North America
Volume65
Issue number3
DOIs
StatePublished - Jun 2018

Keywords

  • Acquired aplastic anemia
  • Autoimmunity
  • Clonality
  • Hematopoietic stem cell
  • Hematopoietic stem cell transplantation
  • Immunosuppressive therapy
  • Myelodysplastic syndrome

Fingerprint

Dive into the research topics of 'Acquired Aplastic Anemia: What Have We Learned and What Is in the Horizon?'. Together they form a unique fingerprint.

Cite this